Opinion/decision on a Paediatric investigation plan (PIP): Oxbryta,Voxelotor, decision type: , therapeutic area: , PIP number: P/0491/2022

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

You just read:

Opinion/decision on a Paediatric investigation plan (PIP): Oxbryta,Voxelotor, decision type: , therapeutic area: , PIP number: P/0491/2022

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.